ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients
South Korean platform biotech company ABL Bio announced that development remains firmly on track despite investor concerns over Sanofi’s recent...
Search results for "Sanofi"
Hanmi Pharm Revives 'LAPSCOVERY' Momentum with $1.26B Eli Lilly Licensing Deal
Hanmi Pharmaceutical has licensed its novel drug candidate sonefpeglutide to global pharmaceutical giant Eli Lilly and Company in a deal valued at up...
Eubiologics Reports Net Profit for Two Consecutive Years, What’s Next?
Cholera vaccine specialist Eubiologics has shown strong performance growth, recording net profits for two consecutive...
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?
American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...
SK Bioscience Launches Quadrivalent Meningococcal Vaccine 'MenQuadfi' in Korea
SK Bioscience announced on the 9th that it has launched the quadrivalent meningococcal conjugate vaccine 'MenQuadfi' in...
Bluebird, Phoenix, and... Who Will Be ABL Bio's Next Technology Export Partner?
After Bluebird and Phoenix, what kind of bird will be the next partner for ABL Bio? ABL Bio is scheduled to meet with...
1